FH and renal cell carcinoma: Uterine leiomyosarcoma has been shown to primarily affect FH carriers with Finnish heritage, and the overall lifetime risk of developing renal cell carcinoma for women with FH mutations has been estimated to be between 1.7% and 5.8% (3, 5).